BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37929279)

  • 61. Guanfu base A, an antiarrhythmic alkaloid of Aconitum coreanum, Is a CYP2D6 inhibitor of human, monkey, and dog isoforms.
    Sun J; Peng Y; Wu H; Zhang X; Zhong Y; Xiao Y; Zhang F; Qi H; Shang L; Zhu J; Sun Y; Liu K; Liu J; A J; Ho RJ; Wang G
    Drug Metab Dispos; 2015 May; 43(5):713-24. PubMed ID: 25681130
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Polymorphism identification within 50 equine gene-specific sequence tagged sites.
    Shubitowski DM; Venta PJ; Douglass CL; Zhou RX; Ewart SL
    Anim Genet; 2001 Apr; 32(2):78-88. PubMed ID: 11421942
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CYP2D plays a major role in berberine metabolism in liver of mice and humans.
    Guo Y; Li F; Ma X; Cheng X; Zhou H; Klaassen CD
    Xenobiotica; 2011 Nov; 41(11):996-1005. PubMed ID: 21787170
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A survey on equine tick-borne diseases: The molecular detection of Babesia ovis DNA in Turkish racehorses.
    Ceylan O; Benedicto B; Ceylan C; Tumwebaze M; Galon EM; Liu M; Xuan X; Sevinc F
    Ticks Tick Borne Dis; 2021 Sep; 12(5):101784. PubMed ID: 34280696
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genetic polymorphism, linkage disequilibrium, haplotype structure and novel allele analysis of CYP2C19 and CYP2D6 in Han Chinese.
    Zhou Q; Yu XM; Lin HB; Wang L; Yun QZ; Hu SN; Wang DM
    Pharmacogenomics J; 2009 Dec; 9(6):380-94. PubMed ID: 19636337
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Design and implementation of a novel pharmacogenetic assay for the identification of the CYP2D6*10 genetic variant.
    Ranadeva NDK; Sirisena ND; Wetthasinghe TK; Noordeen N; Dissanayake VHW
    BMC Res Notes; 2022 Mar; 15(1):104. PubMed ID: 35296326
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Screening of whole genome sequences identified high-impact variants for stallion fertility.
    Schrimpf R; Gottschalk M; Metzger J; Martinsson G; Sieme H; Distl O
    BMC Genomics; 2016 Apr; 17():288. PubMed ID: 27079378
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sequence analysis of the equine SLC26A2 gene locus on chromosome 14q15-->q21.
    Hansen M; Knorr C; Hall AJ; Broad TE; Brenig B
    Cytogenet Genome Res; 2007; 118(1):55-62. PubMed ID: 17901700
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cynomolgus monkey CYP2D44 newly identified in liver, metabolizes bufuralol, and dextromethorphan.
    Uno Y; Uehara S; Kohara S; Murayama N; Yamazaki H
    Drug Metab Dispos; 2010 Sep; 38(9):1486-92. PubMed ID: 20501912
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Rapid detection of common cytochrome P450 2D6 alleles in Caucasians.
    Roberts RL; Kennedy MA
    Clin Chim Acta; 2006 Apr; 366(1-2):348-51. PubMed ID: 16364273
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The repertoire of equine intestinal alpha-defensins.
    Bruhn O; Paul S; Tetens J; Thaller G
    BMC Genomics; 2009 Dec; 10():631. PubMed ID: 20030839
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antiviral potency and functional analysis of tetherin orthologues encoded by horse and donkey.
    Yin X; Guo M; Gu Q; Wu X; Wei P; Wang X
    Virol J; 2014 Aug; 11():151. PubMed ID: 25158826
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmacogenetic aspects of therapy with cholinesterase inhibitors: the role of CYP2D6 in Alzheimer's disease pharmacogenetics.
    Cacabelos R; Llovo R; Fraile C; Fernández-Novoa L
    Curr Alzheimer Res; 2007 Sep; 4(4):479-500. PubMed ID: 17908053
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The endogenous substrates of brain CYP2D.
    Wang X; Li J; Dong G; Yue J
    Eur J Pharmacol; 2014 Feb; 724():211-8. PubMed ID: 24374199
    [TBL] [Abstract][Full Text] [Related]  

  • 75. RNA expression of TLR10 in normal equine tissues.
    Tarlinton RE; Alder L; Moreton J; Maboni G; Emes RD; Tötemeyer S
    BMC Res Notes; 2016 Jul; 9():353. PubMed ID: 27435589
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibition of rat liver CYP2D in vitro and after 1-day and long-term exposure to neuroleptics in vivo-possible involvement of different mechanisms.
    Daniel WA; Haduch A; Wójcikowski J
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):103-10. PubMed ID: 15572279
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nucleotide structure of equine platelet-derived growth factor-A and -B and expression in horses with induced acute tendinitis.
    Donnelly BP; Nixon AJ; Haupt JL; Dahlgren LA
    Am J Vet Res; 2006 Jul; 67(7):1218-25. PubMed ID: 16817746
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CYP2D6, SULT1A1 and UGT2B17 copy number variation: quantitative detection by multiplex PCR.
    Gaedigk A; Twist GP; Leeder JS
    Pharmacogenomics; 2012 Jan; 13(1):91-111. PubMed ID: 22111604
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Whole-genome sequencing and genetic variant analysis of a Quarter Horse mare.
    Doan R; Cohen ND; Sawyer J; Ghaffari N; Johnson CD; Dindot SV
    BMC Genomics; 2012 Feb; 13():78. PubMed ID: 22340285
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The human CYP2D locus associated with a common genetic defect in drug oxidation: a G1934----A base change in intron 3 of a mutant CYP2D6 allele results in an aberrant 3' splice recognition site.
    Hanioka N; Kimura S; Meyer UA; Gonzalez FJ
    Am J Hum Genet; 1990 Dec; 47(6):994-1001. PubMed ID: 1978565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.